Inventor · disambiguated record
Robert H. Brown, Jr.
Also filed as: BROWN JR ROBERT H · BROWN JR ROBERT HADLEY · BROWN ROBERT · BROWN ROBERT H
24 granted patents·12 pending applications·160 citations·filing 1994–2023
95Inventor score
Top patents by PatentIndex Score
36 records- 0196US10711274B2RAAV-based compositions and methods for treating amyotrophic lateral sclerosisUNIV MASSACHUSETTS·Filed 2019·Granted Jul 14, 2020·10 cites·14 claims
- 0295US12312587B2SOD1 dual expression vectors and uses thereofUNIV MASSACHUSETTS·Filed 2023·Granted May 27, 2025·1 cites·26 claims
- 0395US11760999B2RAAV-based compositions and methods for treating amyotrophic lateral sclerosisUNIV MASSACHUSETTS·Filed 2021·Granted Sep 19, 2023·2 cites·29 claims
- 0492US10280418B2RAAV-based compositions and methods for treating amyotrophic lateral sclerosisUNIV MASSACHUSETTS·Filed 2015·Granted May 7, 2019·9 cites·3 claims
- 0590US11739330B2SOD1 dual expression vectors and uses thereofUNIV MASSACHUSETTS·Filed 2018·Granted Aug 29, 2023·3 cites·18 claims
- 0690US10954518B2RAAV-based compositions and methods for treating amyotrophic lateral sclerosisUNIV MASSACHUSETTS·Filed 2019·Granted Mar 23, 2021·2 cites·8 claims
- 0787US2024076668A1Raav-based compositions and methods for treating amyotrophic lateral sclerosisUNIV MASSACHUSETTS·Filed 2023·Application pending·0 cites
- 0886US10851375B2RAAV-based compositions and methods for treating amyotrophic lateral sclerosisUNIV MASSACHUSETTS·Filed 2019·Granted Dec 1, 2020·1 cites·19 claims
- 0986US7452529B2Treatment of muscular dystrophy with cord blood cellsVIACELL INC·Filed 2002·Granted Nov 18, 2008·27 cites·1 claims
- 1084US5543316AInjectable culture medium for maintaining viability of myoblast cellsDIACRIN INC·Filed 1994·Granted Aug 6, 1996·46 cites·38 claims
- 1180US11827886B2Compositions and methods for modulating dysferlin expressionUNIV MASSACHUSETTS·Filed 2020·Granted Nov 28, 2023·1 cites·15 claims
- 1280US10689653B2Compositions and methods for modulating dysferlin expressionUNIV MASSACHUSETTS·Filed 2015·Granted Jun 23, 2020·2 cites·17 claims
- 1379US8841077B2Biomarkers for amyotrophic lateral sclerosis and methods using the samePAIGE LISA A·Filed 2007·Granted Sep 23, 2014·11 cites·10 claims
- 1478US11629347B2Anti-C9ORF72 oligonucleotides and related methodsUNIV MASSACHUSETTS·Filed 2020·Granted Apr 18, 2023·1 cites·33 claims
- 1577US9707703B2Apparatus, kits and methods for the production of biomimetic constructsTULLY FRANCIS MICHAEL NEVES ZUZARTE·Filed 2011·Granted Jul 18, 2017·7 cites·10 claims
- 1676US12378554B2Anti-C9ORF72 oligonucleotides and related methodsUNIV MASSACHUSETTS·Filed 2023·Granted Aug 5, 2025·0 cites·18 claims
- 1770US8753818B1Methods of detecting amyotrophic lateral sclerosis (ALS)UNIV MASSACHUETTS·Filed 2013·Granted Jun 17, 2014·1 cites·14 claims
- 1869US9150860B2FUS/TLS-based compounds and methods for diagnosis, treatment and prevention of amyotrophic lateral sclerosis and related motor neuron diseasesKWIATKOWSKI JR THOMAS J·Filed 2009·Granted Oct 6, 2015·1 cites·2 claims
- 1968US2009068156A1Treatment of muscular dystrophy with cord blood cellsVIACELL INC·Filed 2008·Application pending·0 cites
- 2062US2025327046A1Role of polyphosphates in neurological disordersUNIV MASSACHUSETTS·Filed 2022·Application pending·0 cites
- 2162US2021388444A1Fus/tls-based compounds and methods for diagnosis, treatment and prevention of amyotrophic lateral sclerosis and related motor neuron diseasesTHE GENERAL HOSPITAL CORP D/B/A MASSACHUSETTS GENERAL HOSPITAL·Filed 2021·Application pending·0 cites
- 2261US5780024ASuperoxide dismutase/tetanus toxin fragment C hybrid proteinGEN HOSPITAL CORP·Filed 1996·Granted Jul 14, 1998·23 cites·7 claims
- 2360US12163129B2Antisense oligonucleotides to restore dysferlin protein expression in dysferlinopathy patient cellsUNIV MASSACHUSETTS·Filed 2019·Granted Dec 10, 2024·0 cites·16 claims
- 2460US10258668B2Viral vectors for expressing a modified mullerian inhibiting substance (MIS) proteinMASSACHUSETTS GEN HOSPITAL·Filed 2014·Granted Apr 16, 2019·0 cites·10 claims
- 2557US11041204B2FUS/TLS-based compounds and methods for diagnosis, treatment and prevention of amyotrophic lateral sclerosis and related motor neuron diseasesMASSACHUSETTS GEN HOSPITAL·Filed 2015·Granted Jun 22, 2021·0 cites·6 claims
- 2657US2024011027A1Methods and compositions for restoring stmn2 levelsHARVARD COLLEGE·Filed 2021·Application pending·0 cites
- 2755US2019351026A1Uses of modified mullerian inhibiting substance (mis) proteins for the treatment of neurodegenerative diseasesMASSACHUSETTS GEN HOSPITAL·Filed 2019·Application pending·0 cites
- 2853US2021087568A1Modified Guide RNAs for Gene EditingINTELLIA THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2949US12391947B2Modulation of SPTLC1 via recombinant adeno-associated vectorsUNIV MASSACHUSETTS·Filed 2019·Granted Aug 19, 2025·0 cites·9 claims
- 3048US2005202488A1Assay for therapies that inhibit expression of the cytosolic Cu/Zn superoxide dismutase (SOD1) geneGEN HOSPITAL CORP·Filed 2005·Application pending·0 cites
- 3145US6673909B1Oligonucleotides for dysferlin, a gene mutated in distal myopathy and limb girdle muscular dystrophyGEN HOSPITAL CORP·Filed 1999·Granted Jan 6, 2004·12 cites·1 claims
- 3241US7172858B2Blood-based assay for dysferlinopathiesHOSPITAL STA CREU I SANT PAU·Filed 2002·Granted Feb 6, 2007·0 cites·16 claims
- 3339US2006160168A1Methods and products for identifying compounds that modulate cell plasma membrane repairGEN HOSPITAL CORP·Filed 2006·Application pending·0 cites
- 3438US2018180369A1Systems and methods for locking a magazine to a firearmSPARTAN DEFENSE LLC·Filed 2017·Application pending·0 cites
- 3533US2018228925A1Quantifying Net Axonal Transport in Motor Neuron PathologiesUNIV MASSACHUSETTS·Filed 2016·Application pending·0 cites
- 3629US2003110526A1Dysferlin mutationsFiled 1999·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Robert H. Brown, Jr. files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →